Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 3/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyrolactone SCHEMBL5146838 | 0.93 | CA1 (0.52) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL14931794 | 0.92 | CA1 (0.48) | CA1CA9 | |
| Butyrolactone SCHEMBL2386694 | 0.86 | CA1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| Butyrolactone SCHEMBL5017200 | 0.80 | CA1 (0.44) | CA1CA9ALDH1A1LMNATP53 | |
| Bicarbonate SCHEMBL8606312 | 0.80 | CA1 (0.76) | CA1CA9ALDH1A1LMNATP53 | |
| Hydrogen Peroxide SCHEMBL27660851 | 0.80 | CA1 (0.84) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL16237355 | 0.79 | MAPT (0.30) | MAPT | |
| Propiolactone SCHEMBL6363098 | 0.78 | ALDH1A1 (0.50) | CA1CA9ALDH1A1LMNATP53 | |
| Oxalic Acid SCHEMBL31339544 | 0.78 | CA1 (0.73) | CA1CA9ALDH1A1LMNATP53 | |
| Bicarbonate SCHEMBL2495473 | 0.78 | CA1 (0.80) | CA1CA9ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5366458-A | Latchless surgical clip | UNITED STATES SURGICAL CORPORATION (US) | 1994-11-22 | — | — | US | claimed |
| US-20200208180-A1 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | XYLECO, INC. (US) | 2020-07-02 | — | — | US | disclosed |
| US-10501761-B2 | Processing biomass to obtain hydroxylcarboxylic acids | XYLECO, INC. (US) | 2019-12-10 | — | — | US | disclosed |
| US-20190322800-A1 | PROCESSING HYDROXY-CARBOXYLIC ACIDS TO POLYMERS | XYLECO, INC. (US) | 2019-10-24 | — | — | US | disclosed |
| US-10174160-B2 | Processing hydroxy-carboxylic acids to polymers | XYLECO, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| CN-107286313-A | A kind of degradable polyurethane foam and its application | 陕西瑞盛生物科技有限公司 | 2017-10-24 | — | — | CN | disclosed |
| US-20160076062-A1 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | XYLECO, INC. | 2016-03-17 | — | — | US | disclosed |
| US-20160060386-A1 | PROCESSING HYDROXY-CARBOXYLIC ACIDS TO POLYMERS | XYLECO, INC. | 2016-03-03 | — | — | US | disclosed |
| US-20160053047-A1 | PROCESSING BIOMASS | XYLECO, INC. | 2016-02-25 | — | — | US | disclosed |
| EP-2890794-A2 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | Xyleco, Inc. (US) | 2015-07-08 | — | — | EP | disclosed |
| EP-2890481-A1 | PROCESSING HYDROXY-CARBOXYLIC ACIDS TO POLYMERS | Xyleco, Inc. (US) | 2015-07-08 | — | — | EP | disclosed |
| EP-2890804-A2 | PROCESSING BIOMASS | Xyleco, Inc. (US) | 2015-07-08 | — | — | EP | disclosed |
| WO-2014186670-A2 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014176508-A2 | PROCESSING BIOMASS TO OBTAIN HYDROXYLCARBOXYLIC ACIDS | XYLECO, INC. (US) | 2014-10-30 | — | — | WO | disclosed |
| WO-2014176509-A1 | PROCESSING HYDROXY-CARBOXYLIC ACIDS TO POLYMERS | XYLECO, INC. (US) | 2014-10-30 | — | — | WO | disclosed |
| US-5478354-A | Wound closing apparatus and method | UNITED STATES SURGICAL CORPORATION (US) | 1995-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160053047-A1 | PROCESSING BIOMASS | SCD, FASN, PFAS | CA1 3484/4885CA9 3299/4885ALDH1A1 1704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.